Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.

MLA

Christensen, S., et al. “Introduction of Newer Selective Cyclo-Oxygenase-2 Inhibitors and Rates of Hospitalization with Bleeding and Perforated Peptic Ulcer.” Alimentary Pharmacology & Therapeutics, vol. 25, no. 8, Apr. 2007, pp. 907–12. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2007.03274.x.

APA

Christensen, S., Riis, A., Nørgaard, M., Thomsen, R. W., & Sørensen, H. T. (2007). Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer. Alimentary Pharmacology & Therapeutics, 25(8), 907–912. https://doi.org/10.1111/j.1365-2036.2007.03274.x

Chicago

Christensen, S., A. Riis, M. Nørgaard, R. W. Thomsen, and H. T. Sørensen. 2007. “Introduction of Newer Selective Cyclo-Oxygenase-2 Inhibitors and Rates of Hospitalization with Bleeding and Perforated Peptic Ulcer.” Alimentary Pharmacology & Therapeutics 25 (8): 907–12. doi:10.1111/j.1365-2036.2007.03274.x.